Gene expression in triple-negative breast cancer in relation to survival

[1]  Nan Chen,et al.  There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival. , 2017, Molecular and clinical oncology.

[2]  David E. Williams,et al.  Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. , 2016, Cancer letters.

[3]  P. Sharma,et al.  Biology and Management of Patients With Triple-Negative Breast Cancer. , 2016, The oncologist.

[4]  J. Lee,et al.  Prognostic value of ERBB4 expression in patients with triple negative breast cancer , 2016, BMC Cancer.

[5]  Pankaj Kumar,et al.  An overview of triple-negative breast cancer , 2016, Archives of Gynecology and Obstetrics.

[6]  R. Rosell,et al.  Phase I, dose-escalating study of elisidepsin (Irvalec®), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors , 2016, Investigational New Drugs.

[7]  K. Miller,et al.  Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients , 2016, Cancer Immunology, Immunotherapy.

[8]  S. Hurvitz,et al.  Triple-negative breast cancer: advancements in characterization and treatment approach , 2015, Current opinion in obstetrics & gynecology.

[9]  X. Shu,et al.  ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer , 2015, Oncotarget.

[10]  G. Ciliberto,et al.  Triple negative breast cancer: looking for the missing link between biology and treatments , 2015, Oncotarget.

[11]  B. Chai,et al.  miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  H. Lee,et al.  Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes , 2015, Breast Cancer Research and Treatment.

[13]  S. Ménard,et al.  Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype , 2015, Cancer medicine.

[14]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[15]  X. Shu,et al.  Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome , 2014, Breast Cancer Research and Treatment.

[16]  Z. Werb,et al.  RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth , 2015, Nature Cell Biology.

[17]  X. Shu,et al.  Interactions of Hormone Replacement Therapy, Body Weight, and Bilateral Oophorectomy in Breast Cancer Risk , 2014, Clinical Cancer Research.

[18]  H. Chen,et al.  Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis , 2013, Cell Death and Disease.

[19]  Cheng Hu,et al.  A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans , 2012, Diabetes.

[20]  S. Hemati,et al.  GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility , 2012, Medical Oncology.

[21]  R. Salazar,et al.  A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors , 2012, Cancer Chemotherapy and Pharmacology.

[22]  L. Esserman,et al.  A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. , 2011, JAMA.

[23]  Daniel Birnbaum,et al.  A gene expression signature identifies two prognostic subgroups of basal breast cancer , 2011, Breast Cancer Research and Treatment.

[24]  P. Morel,et al.  T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses , 2010, The Journal of Immunology.

[25]  L. Signorello,et al.  The Southern Community Cohort Study: Investigating Health Disparities , 2010, Journal of health care for the poor and underserved.

[26]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[27]  M. Brito,et al.  Differential expression of GSPT1 GGCn alleles in cancer. , 2009, Cancer genetics and cytogenetics.

[28]  M. Brito,et al.  eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. , 2009, Oncology reports.

[29]  C Polychronakos,et al.  Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies , 2009, Journal of Medical Genetics.

[30]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  S. Moreno,et al.  Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734. , 2008, Cancer research.

[32]  Charles M Perou,et al.  EGFR associated expression profiles vary with breast tumor subtype , 2007, BMC Genomics.

[33]  Zhiyuan Hu,et al.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.

[34]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[35]  D. Pessayre,et al.  The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability , 2005, Pharmacogenetics and genomics.

[36]  Hao Shen,et al.  Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin , 2003, Science.

[37]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[39]  M. Hartman,et al.  Triple negative breast cancer in Asia: An insider's view. , 2018, Cancer treatment reviews.

[40]  S. Probst,et al.  Eomesodermin-At Dawn of Cell Fate Decisions During Early Embryogenesis. , 2017, Current topics in developmental biology.

[41]  A. Jemal,et al.  Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.

[42]  N. Ueno,et al.  A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery , 2015 .

[43]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[44]  Hyun Cheol Chung,et al.  Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells , 2010, Breast Cancer Research and Treatment.

[45]  R. West,et al.  A compact VEGF signature associated with distant metastases and poor outcomes , 2009, BMC medicine.

[46]  T. Koike,et al.  Patients with Systemic Lupus Erythematosus Nucleotide-Releasing Protein 1 in a Subset of Defective Expression of Ras Guanyl , 2007 .